Literature DB >> 1162057

The steepness of the dose-response curve in radiation therapy. Theoretical considerations and experimental results.

J J Fischer, J E Moulder.   

Abstract

The random nature of cell killing by ionizing radiations sets an upper limit on the steepness of the dose-response (D-R) curve for tumor cure. This theoretical limit was approached but not reached in a carefully controlled experimental system. It would seem unlikely that this result could be achieved in clinical practice because of the potential importance of tumor heterogeneity and treatment error in decreasing the slope of the D-R curve. In attempting to achieve a high degree of precision in treatment administration, the therapist, particularly in a multitreatment course, is aided by certain statistical rules which are applicable to random errors.

Entities:  

Mesh:

Year:  1975        PMID: 1162057     DOI: 10.1148/117.1.179

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

Review 1.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Can dose-survival parameters be deduced from in situ assays?

Authors:  T E Wheldon
Journal:  Br J Cancer Suppl       Date:  1980-04

3.  Tumour response endpoints in the BA1112 rat sarcoma.

Authors:  D F Martin; J E Moulder; J J Fischer
Journal:  Br J Cancer Suppl       Date:  1980-04

4.  Theoretical derivation and clinical dose-response quantification of a unified multi-activation (UMA) model of cell survival from a logistic equation.

Authors:  Shidong Li
Journal:  BJR Open       Date:  2021-11-24

5.  The Impact of Positron Emission Tomography/Computed Tomography Addition to Contrast-Enhanced Computed Tomography Findings during Radiation Treatment Planning of Locally Advanced Carcinoma Esophagus.

Authors:  Sharad Bhatnagar; Shweta Sharma; Manoj Semwal; Sankalp Singh
Journal:  J Med Phys       Date:  2019-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.